Changchun GeneScience Pharmaceutical Co., Ltd. (“GenSci”), founded in 1996, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd (stock code 000661). Its administrative headquarters and manufacturing sites are located in Changchun, the capital of Jilin Province; its marketing headquarters are located in Shanghai, and its R&D operations are located in Changchun, Shanghai and Beijing. GenSci is China's “demonstrationcenter for quality control of genetically engineered pharmaceuticals” and “the national incubation site of novel genetically engineered medicines.”

Through 25 years of exploration, GenSci has built a national pilot incubation base for new genetically engineered drugs. The project “Development and Industrialization of Recombinant Human Growth Hormone Products Series” won the second prize in the competition for the National Science and Technology Progress Award for its global innovation leadership and significant contribution to the growth and development of medical field in China. GenSci's products were listed on the “Outstanding Brands of Biological and Biochemical Products in China’s Chemical and Pharmaceutical Industry in 2019”.

GenSci is travelling on the road of innovative medicines and will bring new hopes to patients...